Intech Biopharm
益得生物科技股份有限公司
Intech Biopharm is a Taiwan TPEx-listed biotechnology company; its most advanced asset is Duasma (Commercialized), as of 2026-11-01.
Pipeline
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| Duasma | — | Commercialized | — | Taiwan, Hong Kong, Costa Rica, Mongolia, Philippines, Malaysia | 2026-07-23 | Company disclosure |
| Synbufo | — | Commercialized | — | Taiwan, Costa Rica | 2026-07-23 | Company disclosure |
| Synvent | — | Commercialized | — | Taiwan, Hong Kong, Mongolia, Indonesia, Cambodia, Myanmar | 2026-07-23 | Company disclosure |
Key events
No verified events in the past twelve months.